Expanding into Emerging Markets
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 6 (Table of Contents)
Published: 24 Jun-2009
DOI: 10.3833/pdr.v2009.i6.1126 ISSN: 1756-7874
Section: Editorial
Fulltext:
Abstract
Pharmaceutical companies are increasingly turning their attention to developing nations as they face tougher conditions in the more mature markets coupled with the global economic downturn. Recent deal activity in emerging markets point to a shift in focus by large pharma.
Copyright: © IQVIA 2018